MID-ATLANTIC BIO ANGELS (BioAngels™) GROUP

We invest in exciting life science companies worldwide

Apply for Funding

Review our Investment Criteria and Submit a Funding Application.

Pitch for Feedback

Too early for an investment? Apply to pitch to a panel of our investors for feedback.

FOR INVESTORS

Co-Investors

Learn more about our co-investment (Sidecar Fund).

From Our Blog

MABA Portfolio Company Cerus Endovascular Acquired by Stryker

NEW YORK CITY, NY, USA, May 9, 2023/EINPresswire.com/ -- Mid Atlantic Bio Angels (MABA), a NY-based life science angel investor group, announced today that one of its portfolio companies, Cerus Endovascular Ltd, was acquired in a large transaction by Stryker. Cerus Endovascular Ltd, a UK-based, privately held, commercial stage medical device company focused on the design and development of neurointerventional devices for the treatment of intracranial aneurysms, will join the portfolio of Stryker, one of the world’s leading medical technology companies. MABA’s investment in Cerus Endovascular (Cerus) underscores its commitment to supporting companies that it believes will greatly elevate [ Read more... ]

Previous 91011 Next